Literature DB >> 19031329

Estimation of virological and immunological parameters in subjects from South India infected with human immunodeficiency virus type 1 clade C and correlation of findings with occurrence of neurological disease.

Anupa Kamat1, V Ravi, Anita Desai, P Satishchandra, K S Satish, Mahendra Kumar.   

Abstract

Several studies carried out in Western countries have demonstrated that a number of virological and immunological markers such as viral loads, cytokines, beta(2)-microglobulin, neopterin, etc., are elevated in the serum and cerebrospinal fluid (CSF) of human immunodeficiency virus (HIV)-infected individuals with neurological disease. The neurological manifestations of HIV infection noted in Indian patients is different from those reported in Western countries. Moreover, few studies have investigated the role of virological and immunological parameters with respect to the progression of HIV-1 clade C infection in India. In this study, we measured virological (HIV-1 RNA levels) and immunological parameters (CD4 cell count and inflammatory markers) in the plasma and CSF of HIV-1-infected neurologically asymptomatic and symptomatic (with opportunistic infections and/or dementia) subjects. By using clade-specific polymerase chain reaction (PCR), we ascertained that all samples used for the study were infected with HIV-1 clade C. Among the various laboratory parameters evaluated, high viral loads in the CSF, low CD4 counts, and higher levels of interleukin (IL)-1alpha, IL-6, tumor necrosis factor alpha (TNFalpha), beta(2)-microglobulin, and neopterin were noted in HIV-infected subjects with neurological disease as compared to asymptomatic subjects. These data suggest that the markers evaluated in plasma and CSF samples correlated with occurrence of neurological disease in symptomatic individuals as compared to asymptomatic HIV infected subjects.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19031329     DOI: 10.1080/13550280802338652

Source DB:  PubMed          Journal:  J Neurovirol        ISSN: 1355-0284            Impact factor:   2.643


  37 in total

1.  Cytokine expression in the brain during the acquired immunodeficiency syndrome.

Authors:  W R Tyor; J D Glass; J W Griffin; P S Becker; J C McArthur; L Bezman; D E Griffin
Journal:  Ann Neurol       Date:  1992-04       Impact factor: 10.422

2.  Cerebrospinal fluid beta-2-microglobulin in HIV-1 infection, as a marker of neurological involvement.

Authors:  O Perrella; P B Carrieri; E Izzo; A Marotta; A Liberti; M Soscia; G A Buscaino
Journal:  Neurol Res       Date:  1991-06       Impact factor: 2.448

3.  Cerebrospinal fluid interleukin-6 activity in HIV infection and inflammatory and noninflammatory diseases of the nervous system.

Authors:  M A Laurenzi; A Sidén; M A Persson; G Norkrans; L Hagberg; F Chiodi
Journal:  Clin Immunol Immunopathol       Date:  1990-11

4.  HIV-1 RNA levels in cerebrospinal fluid and plasma and their correlation with opportunistic neurological diseases in a Brazilian AIDS reference hospital.

Authors:  Paulo P Christo; Dirceu B Greco; Agdemir W Aleixo; Jose A Livramento
Journal:  Arq Neuropsiquiatr       Date:  2005-12-15       Impact factor: 1.420

5.  The diagnostic utility of elevation in cerebrospinal fluid beta 2-microglobulin in HIV-1 dementia. Multicenter AIDS Cohort Study.

Authors:  J C McArthur; T E Nance-Sproson; D E Griffin; D Hoover; O A Selnes; E N Miller; J B Margolick; B A Cohen; H Farzadegan; A Saah
Journal:  Neurology       Date:  1992-09       Impact factor: 9.910

6.  Neopterin and interferon-gamma in serum and cerebrospinal fluid of patients with HIV-associated neurologic disease.

Authors:  D E Griffin; J C McArthur; D R Cornblath
Journal:  Neurology       Date:  1991-01       Impact factor: 9.910

7.  Interleukin-6 and granulocyte macrophage-CSF in the cerebrospinal fluid from HIV infected subjects with involvement of the central nervous system.

Authors:  O Perrella; M Guerriero; E Izzo; M Soscia; P B Carrieri
Journal:  Arq Neuropsiquiatr       Date:  1992-06       Impact factor: 1.420

8.  Identification of subtype C human immunodeficiency virus type 1 by subtype-specific PCR and its use in the characterization of viruses circulating in the southern parts of India.

Authors:  Nagadenahalli B Siddappa; Prashanta K Dash; Anita Mahadevan; Narayana Jayasuryan; Fen Hu; Bethany Dice; Randy Keefe; Kadappa S Satish; Bhuthiah Satish; Kuttan Sreekanthan; Ramdas Chatterjee; Kandala Venu; Parthasarathy Satishchandra; Vasanthapuram Ravi; Susarla K Shankar; Raj Shankarappa; Udaykumar Ranga
Journal:  J Clin Microbiol       Date:  2004-06       Impact factor: 5.948

9.  Cellular and serological markers of disease activity in Indian patients with HIV/AIDS.

Authors:  S Sehgal; U Datta; S Mujtaba; A Sood; V K Vinayak
Journal:  Methods Cell Sci       Date:  2002

10.  The prognostic value of cellular and serologic markers in infection with human immunodeficiency virus type 1.

Authors:  J L Fahey; J M Taylor; R Detels; B Hofmann; R Melmed; P Nishanian; J V Giorgi
Journal:  N Engl J Med       Date:  1990-01-18       Impact factor: 91.245

View more
  4 in total

1.  Impact of the HIV Tat C30C31S dicysteine substitution on neuropsychological function in patients with clade C disease.

Authors:  Robert H Paul; John A Joska; Carol Woods; Soraya Seedat; Susan Engelbrecht; Jacqueline Hoare; Jodi Heaps; Victor Valcour; Beau Ances; Laurie M Baker; Lauren E Salminen; Dan J Stein
Journal:  J Neurovirol       Date:  2014-11-01       Impact factor: 2.643

Review 2.  Targeting TNF-α to elucidate and ameliorate neuroinflammation in neurodegenerative diseases.

Authors:  Kathryn A Frankola; Nigel H Greig; Weiming Luo; David Tweedie
Journal:  CNS Neurol Disord Drug Targets       Date:  2011-05       Impact factor: 4.388

3.  HIV-1 clade B and C isolates exhibit differential replication: relevance to macrophage-mediated neurotoxicity.

Authors:  Agnes A Constantino; Yunlong Huang; Hong Zhang; Charles Wood; Jialin C Zheng
Journal:  Neurotox Res       Date:  2011-02-19       Impact factor: 3.911

4.  Global NeuroAIDS roundtable.

Authors:  Jeymohan Joseph; Cristian L Achim; Michael J Boivin; Bruce J Brew; David B Clifford; Deborah A Colosi; Ronald J Ellis; Robert K Heaton; Amadou Gallo-Diop; Igor Grant; Georgette D Kanmogne; Mahendra Kumar; Scott Letendre; Thomas D Marcotte; Avindra Nath; Carlos A Pardo; Robert H Paul; Lynn Pulliam; Kevin Robertson; Walter Royal; Ned Sacktor; Pasiri Sithinamsuwan; Davey M Smith; Victor Valcour; Brian Wigdahl; Charles Wood
Journal:  J Neurovirol       Date:  2013-01-26       Impact factor: 2.643

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.